Where is the live CopyMark page for USPTO serial 79219799?

The live record is at https://getcopymark.com/trademark/79219799. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns ENDORET GEL?

According to the public USPTO record for serial number 79219799, the listed owner(s) include: BIOTECHNOLOGY INSTITUTE, S.L., BIOTECHNOLOGY INSTITUTE, S.L., BIOTECHNOLOGY INSTITUTE, S.L..

What is USPTO serial number 79219799?

Serial number 79219799 is the USPTO application identifier for the mark ENDORET GEL. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover ENDORET GEL?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: ENDORET GEL Serial# 79219799 | status 709; last event INNT | Trademark Info & Attorney Guidance

Q: What is the current status of ENDORET GEL?

ENDORET GEL (79219799) currently shows USPTO status code 709 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ENDORET GEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOSE MARIA ARRUFAT

JOSE MARIA ARRUFAT ARRUFAT GRACIA PLLC54 WEST, 40TH STREET, SUITE 816NEW YORK, NY 10018UNITED STATES

Goods and services

Class	Description	Status	First use
005	Biomaterial obtained from blood and consisting exclusively of human plasma, intended for tissue regeneration and for medical, therapeutic and/or esthetic purposes; blood plasma rich in growth factors	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jan 22, 2026	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Jan 6, 2026	INTS	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Jan 6, 2026	INPC	INVALIDATION PROCESSED	—
Jul 15, 2025	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Nov 15, 2024	C71T	CANCELLED SECTION 71	—
Jan 19, 2024	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
May 1, 2023	REM3	COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED	—
Oct 21, 2019	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2019	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Oct 4, 2019	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 4, 2019	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Sep 7, 2018	FINV	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Aug 13, 2018	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Aug 13, 2018	FIMP	FINAL DISPOSITION PROCESSED	—
Aug 1, 2018	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
May 1, 2018	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 13, 2018	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Feb 13, 2018	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2018	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Jan 2, 2018	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Dec 13, 2017	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Dec 12, 2017	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Dec 12, 2017	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2017	RFNT	REFUSAL PROCESSED BY IB	—
Nov 17, 2017	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Nov 17, 2017	RFRR	REFUSAL PROCESSED BY MPU	—
Nov 7, 2017	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Nov 7, 2017	MAFR	APPLICATION FILING RECEIPT MAILED	—
Nov 6, 2017	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 3, 2017	DOCK	ASSIGNED TO EXAMINER	—
Nov 3, 2017	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Nov 2, 2017	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

ENDORET GEL